HCPCS code J9333 — Inj rozanolixizum-noli 1 mg. Status: Active. Effective Oct 1, 2025. Source: CMS HCPCS Level II.

J9333

Active

Inj rozanolixizum-noli 1 mg

Injection, rozanolixizumab-noli, 1 mg

Category: Drugs
Section: J-codes: Drugs Administered Other Than Oral Method
Effective: Oct 1, 2025
Code type: alphanumeric
OPPS Status: G — Pass-through drugs and biologicals
OPPS APC: 0721

MUE — Medically Unlikely Edits

Maximum units of J9333 Medicare will pay for one beneficiary on one date of service. Claims exceeding the MUE are denied or returned for review.

Service Type Max Units / Day
Outpatient Hospital 840
Practitioner Services 840

Source: CMS Medicare NCCI Medically Unlikely Edits

NDC Crosswalk

National Drug Codes (NDCs) mapped to this HCPCS code.

NDC Drug Name
50474-0980-79 Rystiggo
50474-0981-83 Rystiggo
50474-0982-84 Rystiggo
50474-0983-86 Rystiggo

Change History

Quarterly changes published by CMS. Revisions may affect the code description, coverage, or rate — review each quarter's changes before submitting claims.

  • Revised 2025-Q4
    Inj ronzanolixizum-noli 1 mg
    Inj rozanolixizum-noli 1 mg
  • New Code 2025-Q4
    Inj rozanolixizum-noli 1 mg